LifeMD (LFMD)
(Delayed Data from NSDQ)
$4.73 USD
+0.01 (0.21%)
Updated Jan 14, 2025 04:00 PM ET
After-Market: $4.73 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
LifeMD, Inc. (LFMD) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$11.69 | $16.00 | $7.00 | 147.67% |
Find the top stocks with the greatest target price potential and Zacks Rank of 1 or 2
Price Target
Based on short-term price targets offered by eight analysts, the average price target for LifeMD, Inc. comes to $11.69. The forecasts range from a low of $7.00 to a high of $16.00. The average price target represents an increase of 147.67% from the last closing price of $4.72.
Analyst Price Targets (8 )
Find the top stocks with the greatest price target potential and Zacks Rank of 1 or 2
Broker Rating
LifeMD, Inc. currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by eight brokerage firms. The current ABR compares to an ABR of 1.25 a month ago based on eight recommendations.
Of the eight recommendations deriving the current ABR, seven are Strong Buy, representing 87.5% of all recommendations. A month ago, Strong Buy represented 87.5%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 7 | 7 | 7 | 6 | 6 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.25 | 1.25 | 1.25 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
1/8/2025 | KeyBanc Capital Markets | Scott Schoenhaus | Strong Buy | Strong Buy |
12/10/2024 | Lake Street Capital Markets | Brooks G O'Neil | Not Available | Strong Buy |
12/4/2024 | Mizuho SecuritiesUSA | Steven Valiquette | Not Available | Hold |
11/11/2024 | H.C. Wainwright & Co. | Yi Chen | Strong Buy | Strong Buy |
11/8/2024 | Craig-Hallum | Alex J Fuhrman | Strong Buy | Strong Buy |
11/8/2024 | Cantor Fitzgerald & Co | Sarah James | Strong Buy | Strong Buy |
9/24/2024 | BTIG | David M Larsen | Strong Buy | Strong Buy |
8/23/2024 | B. Riley Securities | Kyle Bauser | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.25 |
ABR (Last week) | 1.25 |
# of Recs in ABR | 8 |
Average Target Price | $11.69 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 148 of 251 |
Current Quarter EPS Est: | -0.06 |
LFMD FAQs
LifeMD, Inc. (LFMD) currently has an average brokerage recommendation (ABR) of 1.25 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 8 brokerage firms.
The average price target for LifeMD, Inc. (LFMD) is $11.69. The current on short-term price targets is based on 8 reports.
The forecasts for LifeMD, Inc. (LFMD) range from a low of $7 to a high of $16. The average price target represents a increase of $147.67 from the last closing price of $4.72.
The current UPSIDE for LifeMD, Inc. (LFMD) is 147.67%
Based on short-term price targets offered by eight analysts, the average price target for LifeMD, Inc. comes to $11.69. The forecasts range from a low of $7.00 to a high of $16.00. The average price target represents an increase of 147.67% from the last closing price of $4.72.